UBQLN4 and esophageal squamous cell carcinoma: As a predictive biomarker of drug resistance, UBQLN4 mRNA levels are associated with the efficacy of neoadjuvant chemotherapy (NAC) including platinum-based chemotherapeutic agents in ESCC [8].